2008-2017 © InTouch BioSolutions LLC.  All Rights Reserved.

InTouch Bio Services Contact Us

Jay Dela Cruz, Ph.D. is President and Founder of InTouch BioSolutions LLC. He continues to participate hands-on and serves as Scientific Director.

Dr. Dela Cruz has worked with various ex-vivo and in-vivo models that have led to an invention and numerous publications. At Genentech (now a member of the Roche Group) and KAI Pharmaceuticals (acquired by Amgen Inc.) he evaluated candidate antibody, small molecule- and peptide-based therapeutics against cancer and various autoimmune diseases in vivo. He also developed and discovered clinically-relevant drug biomarkers.

Dr. Dela Cruz shares the belief that the shortest path to understanding drug effect and mechanism of action is to evaluate its activity in validated cell assay systems. Successful evaluation of compound activity at the level of cellular function requires many years of experience with industry-standard cell isolation and cell differentiation methods as well as a passion for working with various types of cell-based assay systems. These are the qualities that Dr. Dela Cruz fosters at InTouch Bio.


Pre-clinical Research Services